nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent ethyl—DGAT1—prostate gland—prostate cancer	0.037	0.264	CbGeAlD
Icosapent ethyl—DGAT1—seminal vesicle—prostate cancer	0.0313	0.223	CbGeAlD
Icosapent ethyl—DGAT1—urethra—prostate cancer	0.0247	0.177	CbGeAlD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—ALDH1A2—prostate cancer	0.0224	0.0783	CbGpPWpGaD
Icosapent ethyl—DGAT1—bone marrow—prostate cancer	0.019	0.136	CbGeAlD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—SULT2B1—prostate cancer	0.0179	0.0626	CbGpPWpGaD
Icosapent ethyl—DGAT1—testis—prostate cancer	0.0163	0.116	CbGeAlD
Icosapent ethyl—DGAT1—Statin Pathway—ABCG5—prostate cancer	0.0132	0.0461	CbGpPWpGaD
Icosapent ethyl—DGAT1—Triglyceride Biosynthesis—HSD17B3—prostate cancer	0.013	0.0454	CbGpPWpGaD
Icosapent ethyl—DGAT1—Triglyceride Biosynthesis—ACSL4—prostate cancer	0.013	0.0454	CbGpPWpGaD
Icosapent ethyl—DGAT1—lymph node—prostate cancer	0.0118	0.0842	CbGeAlD
Icosapent ethyl—Icosapent—ACSL4—prostate cancer	0.0112	0.857	CrCbGaD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—SULT1A1—prostate cancer	0.00964	0.0337	CbGpPWpGaD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—ABCG5—prostate cancer	0.00964	0.0337	CbGpPWpGaD
Icosapent ethyl—DGAT1—Triacylglyceride Synthesis—LPL—prostate cancer	0.0072	0.0251	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—GRHL1—prostate cancer	0.00652	0.0228	CbGpPWpGaD
Icosapent ethyl—DGAT1—Statin Pathway—LPL—prostate cancer	0.00619	0.0216	CbGpPWpGaD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—CYP2E1—prostate cancer	0.00607	0.0212	CbGpPWpGaD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—RXRA—prostate cancer	0.00522	0.0182	CbGpPWpGaD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—LPL—prostate cancer	0.00451	0.0158	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—TNFRSF21—prostate cancer	0.00432	0.0151	CbGpPWpGaD
Icosapent ethyl—DGAT1—Glycerophospholipid biosynthesis—ACHE—prostate cancer	0.00407	0.0142	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—HSD17B3—prostate cancer	0.00391	0.0136	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—ACSL4—prostate cancer	0.00391	0.0136	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—ACHE—prostate cancer	0.00284	0.00992	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—SULT2A1—prostate cancer	0.00264	0.00922	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CBR1—prostate cancer	0.0026	0.00907	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—GRHL1—prostate cancer	0.0026	0.00907	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—prostate cancer	0.0026	0.00907	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOA3—prostate cancer	0.00248	0.00866	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—MBTPS1—prostate cancer	0.00227	0.00793	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—AMACR—prostate cancer	0.00215	0.00751	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—DEGS1—prostate cancer	0.00215	0.00751	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—SRD5A2—prostate cancer	0.00215	0.00751	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOA2—prostate cancer	0.00207	0.00723	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—HSD17B1—prostate cancer	0.00205	0.00717	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—HPGD—prostate cancer	0.00183	0.00639	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOA1—prostate cancer	0.00175	0.00609	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—TNFRSF21—prostate cancer	0.00172	0.00601	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CYP7B1—prostate cancer	0.00167	0.00584	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—prostate cancer	0.00166	0.0058	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—SRD5A1—prostate cancer	0.00163	0.00569	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ACSL4—prostate cancer	0.00156	0.00543	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—HSD17B3—prostate cancer	0.00156	0.00543	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—HAO1—prostate cancer	0.00142	0.00495	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—prostate cancer	0.00139	0.00484	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PIK3CG—prostate cancer	0.00134	0.00469	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	0.00132	0.00462	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	0.00127	0.00443	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—prostate cancer	0.00127	0.00443	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	0.00122	0.00426	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PIK3CD—prostate cancer	0.00118	0.00412	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	0.00118	0.00412	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CSAD—prostate cancer	0.00116	0.00404	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—TST—prostate cancer	0.00116	0.00404	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GRHL1—prostate cancer	0.00116	0.00404	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PSAT1—prostate cancer	0.00116	0.00404	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ADI1—prostate cancer	0.00116	0.00404	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CBR1—prostate cancer	0.00116	0.00404	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	0.00113	0.00395	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	0.00111	0.00387	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CKMT2—prostate cancer	0.00108	0.00375	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—UGT2B17—prostate cancer	0.00108	0.00375	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—UGT2B15—prostate cancer	0.00108	0.00375	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GRHPR—prostate cancer	0.00108	0.00375	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	0.00105	0.00367	CbGpPWpGaD
Icosapent ethyl—Dihomo-gamma-linolenic acid—PTGS2—prostate cancer	0.00105	0.0804	CrCbGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—MED12—prostate cancer	0.00103	0.00361	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PIK3CB—prostate cancer	0.00103	0.00359	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GSTM3—prostate cancer	0.00101	0.00353	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PGAM2—prostate cancer	0.00101	0.00353	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—AOX1—prostate cancer	0.00101	0.00353	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—MBTPS1—prostate cancer	0.00101	0.00353	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—RFK—prostate cancer	0.00101	0.00353	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NAGLU—prostate cancer	0.00101	0.00353	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SULT2B1—prostate cancer	0.00101	0.00353	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—prostate cancer	0.00101	0.00352	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	0.000988	0.00345	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—AMACR—prostate cancer	0.000959	0.00335	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CYP3A43—prostate cancer	0.000959	0.00335	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SRD5A2—prostate cancer	0.000959	0.00335	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NAT1—prostate cancer	0.000959	0.00335	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—DEGS1—prostate cancer	0.000959	0.00335	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	0.000943	0.00329	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	0.000937	0.00327	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—HSD17B1—prostate cancer	0.000914	0.00319	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	0.000914	0.00319	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PTEN—prostate cancer	0.000889	0.00311	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	0.000879	0.00307	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	0.000875	0.00305	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	0.000866	0.00302	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	0.000825	0.00288	CbGpPWpGaD
Icosapent ethyl—Icosapent—PTGS2—prostate cancer	0.000821	0.0631	CrCbGaD
Icosapent ethyl—DGAT1—Metabolism—HPGD—prostate cancer	0.000815	0.00285	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—B4GALT4—prostate cancer	0.000815	0.00285	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—TNFRSF21—prostate cancer	0.000766	0.00268	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—MTAP—prostate cancer	0.000745	0.0026	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CYP7B1—prostate cancer	0.000745	0.0026	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	0.000729	0.00254	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SULT1E1—prostate cancer	0.000726	0.00254	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SRD5A1—prostate cancer	0.000726	0.00254	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	0.000706	0.00246	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	0.000695	0.00243	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ACSL4—prostate cancer	0.000693	0.00242	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—HSD17B3—prostate cancer	0.000693	0.00242	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—prostate cancer	0.000686	0.00239	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	0.000685	0.00239	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ARG2—prostate cancer	0.000664	0.00232	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PHGDH—prostate cancer	0.000664	0.00232	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—UMPS—prostate cancer	0.000664	0.00232	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	0.000661	0.00231	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—LDHB—prostate cancer	0.000652	0.00227	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CYP3A5—prostate cancer	0.00064	0.00223	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PIK3CA—prostate cancer	0.000627	0.00219	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GSTA3—prostate cancer	0.000618	0.00216	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—TCN2—prostate cancer	0.000618	0.00216	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—UCP3—prostate cancer	0.000618	0.00216	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PDHA1—prostate cancer	0.000618	0.00216	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SLC22A3—prostate cancer	0.000589	0.00206	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—HSD3B1—prostate cancer	0.000589	0.00206	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—LPL—prostate cancer	0.000572	0.002	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—TBXAS1—prostate cancer	0.000565	0.00197	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GSTA4—prostate cancer	0.000565	0.00197	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	0.000552	0.00193	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GSTA2—prostate cancer	0.000551	0.00192	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ABCG5—prostate cancer	0.000544	0.0019	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SULT1A1—prostate cancer	0.000544	0.0019	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GSTA1—prostate cancer	0.000531	0.00185	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NAT2—prostate cancer	0.000525	0.00183	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—HSD3B2—prostate cancer	0.000525	0.00183	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GSTO1—prostate cancer	0.000525	0.00183	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	0.000505	0.00176	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PLCB2—prostate cancer	0.000504	0.00176	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—LRP2—prostate cancer	0.000504	0.00176	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CYP2C18—prostate cancer	0.000504	0.00176	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—P4HB—prostate cancer	0.000494	0.00172	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SLC22A1—prostate cancer	0.00048	0.00168	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	0.000475	0.00166	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SULT2A1—prostate cancer	0.000468	0.00163	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—MED12—prostate cancer	0.000461	0.00161	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GNG5—prostate cancer	0.000457	0.0016	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NCOA3—prostate cancer	0.00044	0.00154	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	0.000432	0.00151	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—HPGDS—prostate cancer	0.00042	0.00147	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CYP2C19—prostate cancer	0.000417	0.00146	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GSTT1—prostate cancer	0.000407	0.00142	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ACHE—prostate cancer	0.000407	0.00142	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CYP2A6—prostate cancer	0.000403	0.00141	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	0.000401	0.0014	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—AKR1C3—prostate cancer	0.000392	0.00137	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PRKACB—prostate cancer	0.00039	0.00136	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CYP17A1—prostate cancer	0.000385	0.00135	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	0.00038	0.00133	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NCOA2—prostate cancer	0.000367	0.00128	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SLC5A5—prostate cancer	0.00035	0.00122	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CYP2E1—prostate cancer	0.000342	0.00119	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NQO1—prostate cancer	0.000338	0.00118	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—TH—prostate cancer	0.000334	0.00116	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	0.000331	0.00116	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CYP3A4—prostate cancer	0.00033	0.00115	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	0.000328	0.00115	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CYP1B1—prostate cancer	0.000324	0.00113	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GGT1—prostate cancer	0.000314	0.0011	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NCOA1—prostate cancer	0.00031	0.00108	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CYP19A1—prostate cancer	0.000305	0.00107	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—RXRA—prostate cancer	0.000294	0.00103	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	0.000286	0.001	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—COMT—prostate cancer	0.000284	0.00099	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GSTP1—prostate cancer	0.000282	0.000985	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ITPR1—prostate cancer	0.000278	0.00097	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	0.000273	0.000953	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—TYMS—prostate cancer	0.000262	0.000916	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GSTM1—prostate cancer	0.000259	0.000906	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—LPL—prostate cancer	0.000255	0.000889	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CYP1A1—prostate cancer	0.000246	0.000859	CbGpPWpGaD
Icosapent ethyl—Alopecia—Capecitabine—prostate cancer	0.000245	0.000437	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Etoposide—prostate cancer	0.000245	0.000437	CcSEcCtD
Icosapent ethyl—Mood swings—Doxorubicin—prostate cancer	0.000245	0.000436	CcSEcCtD
Icosapent ethyl—Dysgeusia—Docetaxel—prostate cancer	0.000244	0.000435	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—ERCC2—prostate cancer	0.000244	0.000851	CbGpPWpGaD
Icosapent ethyl—Infection—Etoposide—prostate cancer	0.000243	0.000434	CcSEcCtD
Icosapent ethyl—Abdominal distension—Epirubicin—prostate cancer	0.000243	0.000433	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Mitoxantrone—prostate cancer	0.000242	0.000433	CcSEcCtD
Icosapent ethyl—Malnutrition—Capecitabine—prostate cancer	0.000241	0.00043	CcSEcCtD
Icosapent ethyl—Dysphagia—Epirubicin—prostate cancer	0.000241	0.00043	CcSEcCtD
Icosapent ethyl—Influenza—Epirubicin—prostate cancer	0.000241	0.00043	CcSEcCtD
Icosapent ethyl—Asthma—Epirubicin—prostate cancer	0.000241	0.00043	CcSEcCtD
Icosapent ethyl—Back pain—Docetaxel—prostate cancer	0.000241	0.00043	CcSEcCtD
Icosapent ethyl—Tachycardia—Etoposide—prostate cancer	0.000239	0.000426	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Etoposide—prostate cancer	0.000237	0.000422	CcSEcCtD
Icosapent ethyl—Pancreatitis—Epirubicin—prostate cancer	0.000236	0.000422	CcSEcCtD
Icosapent ethyl—Dysgeusia—Capecitabine—prostate cancer	0.000236	0.000422	CcSEcCtD
Icosapent ethyl—Angina pectoris—Epirubicin—prostate cancer	0.000235	0.000419	CcSEcCtD
Icosapent ethyl—Back pain—Capecitabine—prostate cancer	0.000233	0.000416	CcSEcCtD
Icosapent ethyl—Anorexia—Etoposide—prostate cancer	0.000233	0.000416	CcSEcCtD
Icosapent ethyl—Body temperature increased—Mitoxantrone—prostate cancer	0.000233	0.000415	CcSEcCtD
Icosapent ethyl—Aspartate aminotransferase increased—Doxorubicin—prostate cancer	0.000233	0.000415	CcSEcCtD
Icosapent ethyl—Bronchitis—Epirubicin—prostate cancer	0.000232	0.000414	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—MTHFR—prostate cancer	0.000229	0.0008	CbGpPWpGaD
Icosapent ethyl—Gastritis—Doxorubicin—prostate cancer	0.000229	0.000408	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Doxorubicin—prostate cancer	0.000228	0.000406	CcSEcCtD
Icosapent ethyl—Asthenia—Estradiol—prostate cancer	0.000227	0.000404	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—PPARA—prostate cancer	0.000225	0.000785	CbGpPWpGaD
Icosapent ethyl—Abdominal distension—Doxorubicin—prostate cancer	0.000225	0.000401	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Capecitabine—prostate cancer	0.000224	0.000399	CcSEcCtD
Icosapent ethyl—Syncope—Docetaxel—prostate cancer	0.000223	0.000399	CcSEcCtD
Icosapent ethyl—Pruritus—Estradiol—prostate cancer	0.000223	0.000399	CcSEcCtD
Icosapent ethyl—Influenza—Doxorubicin—prostate cancer	0.000223	0.000398	CcSEcCtD
Icosapent ethyl—Dysphagia—Doxorubicin—prostate cancer	0.000223	0.000398	CcSEcCtD
Icosapent ethyl—Asthma—Doxorubicin—prostate cancer	0.000223	0.000398	CcSEcCtD
Icosapent ethyl—Arrhythmia—Prednisone—prostate cancer	0.000221	0.000393	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Docetaxel—prostate cancer	0.000219	0.000391	CcSEcCtD
Icosapent ethyl—Pancreatitis—Doxorubicin—prostate cancer	0.000219	0.00039	CcSEcCtD
Icosapent ethyl—Dyspnoea—Etoposide—prostate cancer	0.000218	0.000389	CcSEcCtD
Icosapent ethyl—Alopecia—Prednisone—prostate cancer	0.000218	0.000389	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Epirubicin—prostate cancer	0.000218	0.000388	CcSEcCtD
Icosapent ethyl—Malaise—Capecitabine—prostate cancer	0.000218	0.000388	CcSEcCtD
Icosapent ethyl—Cough—Docetaxel—prostate cancer	0.000217	0.000388	CcSEcCtD
Icosapent ethyl—Angina pectoris—Doxorubicin—prostate cancer	0.000217	0.000388	CcSEcCtD
Icosapent ethyl—Vertigo—Capecitabine—prostate cancer	0.000217	0.000387	CcSEcCtD
Icosapent ethyl—Syncope—Capecitabine—prostate cancer	0.000216	0.000386	CcSEcCtD
Icosapent ethyl—Pneumonia—Epirubicin—prostate cancer	0.000216	0.000386	CcSEcCtD
Icosapent ethyl—Hypertension—Docetaxel—prostate cancer	0.000215	0.000384	CcSEcCtD
Icosapent ethyl—Infestation NOS—Epirubicin—prostate cancer	0.000215	0.000384	CcSEcCtD
Icosapent ethyl—Infestation—Epirubicin—prostate cancer	0.000215	0.000384	CcSEcCtD
Icosapent ethyl—Malnutrition—Prednisone—prostate cancer	0.000215	0.000383	CcSEcCtD
Icosapent ethyl—Bronchitis—Doxorubicin—prostate cancer	0.000215	0.000383	CcSEcCtD
Icosapent ethyl—Decreased appetite—Etoposide—prostate cancer	0.000213	0.00038	CcSEcCtD
Icosapent ethyl—Chest pain—Docetaxel—prostate cancer	0.000212	0.000379	CcSEcCtD
Icosapent ethyl—Myalgia—Docetaxel—prostate cancer	0.000212	0.000379	CcSEcCtD
Icosapent ethyl—Arthralgia—Docetaxel—prostate cancer	0.000212	0.000379	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Capecitabine—prostate cancer	0.000212	0.000378	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—CAV1—prostate cancer	0.000211	0.000738	CbGpPWpGaD
Icosapent ethyl—Gastrointestinal disorder—Etoposide—prostate cancer	0.000211	0.000377	CcSEcCtD
Icosapent ethyl—Asthenia—Mitoxantrone—prostate cancer	0.000211	0.000377	CcSEcCtD
Icosapent ethyl—Cough—Capecitabine—prostate cancer	0.000211	0.000376	CcSEcCtD
Icosapent ethyl—Pain—Etoposide—prostate cancer	0.000209	0.000373	CcSEcCtD
Icosapent ethyl—Constipation—Etoposide—prostate cancer	0.000209	0.000373	CcSEcCtD
Icosapent ethyl—Dizziness—Estradiol—prostate cancer	0.000209	0.000373	CcSEcCtD
Icosapent ethyl—Hypertension—Capecitabine—prostate cancer	0.000208	0.000372	CcSEcCtD
Icosapent ethyl—Dry mouth—Docetaxel—prostate cancer	0.000207	0.00037	CcSEcCtD
Icosapent ethyl—Sweating—Epirubicin—prostate cancer	0.000206	0.000368	CcSEcCtD
Icosapent ethyl—Arthralgia—Capecitabine—prostate cancer	0.000205	0.000366	CcSEcCtD
Icosapent ethyl—Chest pain—Capecitabine—prostate cancer	0.000205	0.000366	CcSEcCtD
Icosapent ethyl—Myalgia—Capecitabine—prostate cancer	0.000205	0.000366	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Docetaxel—prostate cancer	0.000203	0.000363	CcSEcCtD
Icosapent ethyl—Oedema—Docetaxel—prostate cancer	0.000203	0.000363	CcSEcCtD
Icosapent ethyl—Discomfort—Capecitabine—prostate cancer	0.000203	0.000362	CcSEcCtD
Icosapent ethyl—Epistaxis—Epirubicin—prostate cancer	0.000203	0.000362	CcSEcCtD
Icosapent ethyl—Infection—Docetaxel—prostate cancer	0.000202	0.00036	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	0.000202	0.000705	CbGpPWpGaD
Icosapent ethyl—Sinusitis—Epirubicin—prostate cancer	0.000202	0.00036	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Etoposide—prostate cancer	0.000202	0.00036	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Doxorubicin—prostate cancer	0.000201	0.000359	CcSEcCtD
Icosapent ethyl—Dry mouth—Capecitabine—prostate cancer	0.000201	0.000358	CcSEcCtD
Icosapent ethyl—Vomiting—Estradiol—prostate cancer	0.000201	0.000358	CcSEcCtD
Icosapent ethyl—Pneumonia—Doxorubicin—prostate cancer	0.0002	0.000357	CcSEcCtD
Icosapent ethyl—Shock—Docetaxel—prostate cancer	0.0002	0.000357	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Prednisone—prostate cancer	0.000199	0.000356	CcSEcCtD
Icosapent ethyl—Rash—Estradiol—prostate cancer	0.000199	0.000355	CcSEcCtD
Icosapent ethyl—Infestation NOS—Doxorubicin—prostate cancer	0.000199	0.000355	CcSEcCtD
Icosapent ethyl—Infestation—Doxorubicin—prostate cancer	0.000199	0.000355	CcSEcCtD
Icosapent ethyl—Dermatitis—Estradiol—prostate cancer	0.000199	0.000355	CcSEcCtD
Icosapent ethyl—Tachycardia—Docetaxel—prostate cancer	0.000198	0.000354	CcSEcCtD
Icosapent ethyl—Oedema—Capecitabine—prostate cancer	0.000197	0.000351	CcSEcCtD
Icosapent ethyl—Infection—Capecitabine—prostate cancer	0.000196	0.000349	CcSEcCtD
Icosapent ethyl—Anorexia—Docetaxel—prostate cancer	0.000194	0.000346	CcSEcCtD
Icosapent ethyl—Malaise—Prednisone—prostate cancer	0.000194	0.000346	CcSEcCtD
Icosapent ethyl—Shock—Capecitabine—prostate cancer	0.000194	0.000346	CcSEcCtD
Icosapent ethyl—Rhinitis—Epirubicin—prostate cancer	0.000194	0.000345	CcSEcCtD
Icosapent ethyl—Body temperature increased—Etoposide—prostate cancer	0.000193	0.000345	CcSEcCtD
Icosapent ethyl—Vertigo—Prednisone—prostate cancer	0.000193	0.000344	CcSEcCtD
Icosapent ethyl—Syncope—Prednisone—prostate cancer	0.000193	0.000344	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—PIK3CG—prostate cancer	0.000193	0.000672	CbGpPWpGaD
Icosapent ethyl—Tachycardia—Capecitabine—prostate cancer	0.000192	0.000343	CcSEcCtD
Icosapent ethyl—Pharyngitis—Epirubicin—prostate cancer	0.000192	0.000342	CcSEcCtD
Icosapent ethyl—Sweating—Doxorubicin—prostate cancer	0.000191	0.00034	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Capecitabine—prostate cancer	0.00019	0.00034	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Prednisone—prostate cancer	0.000189	0.000337	CcSEcCtD
Icosapent ethyl—Epistaxis—Doxorubicin—prostate cancer	0.000188	0.000335	CcSEcCtD
Icosapent ethyl—Anorexia—Capecitabine—prostate cancer	0.000188	0.000335	CcSEcCtD
Icosapent ethyl—Vomiting—Mitoxantrone—prostate cancer	0.000187	0.000334	CcSEcCtD
Icosapent ethyl—Sinusitis—Doxorubicin—prostate cancer	0.000187	0.000333	CcSEcCtD
Icosapent ethyl—Hypertension—Prednisone—prostate cancer	0.000186	0.000331	CcSEcCtD
Icosapent ethyl—Rash—Mitoxantrone—prostate cancer	0.000185	0.000331	CcSEcCtD
Icosapent ethyl—Dermatitis—Mitoxantrone—prostate cancer	0.000185	0.000331	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000185	0.000331	CcSEcCtD
Icosapent ethyl—Insomnia—Docetaxel—prostate cancer	0.000184	0.000328	CcSEcCtD
Icosapent ethyl—Myalgia—Prednisone—prostate cancer	0.000183	0.000326	CcSEcCtD
Icosapent ethyl—Arthralgia—Prednisone—prostate cancer	0.000183	0.000326	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—INS—prostate cancer	0.000182	0.000637	CbGpPWpGaD
Icosapent ethyl—Dyspnoea—Docetaxel—prostate cancer	0.000181	0.000323	CcSEcCtD
Icosapent ethyl—Discomfort—Prednisone—prostate cancer	0.000181	0.000323	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000179	0.00032	CcSEcCtD
Icosapent ethyl—Rhinitis—Doxorubicin—prostate cancer	0.000179	0.00032	CcSEcCtD
Icosapent ethyl—Dyspepsia—Docetaxel—prostate cancer	0.000179	0.000319	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—CREBBP—prostate cancer	0.000179	0.000623	CbGpPWpGaD
Icosapent ethyl—Insomnia—Capecitabine—prostate cancer	0.000178	0.000318	CcSEcCtD
Icosapent ethyl—Pharyngitis—Doxorubicin—prostate cancer	0.000177	0.000316	CcSEcCtD
Icosapent ethyl—Decreased appetite—Docetaxel—prostate cancer	0.000177	0.000315	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000176	0.000313	CcSEcCtD
Icosapent ethyl—Asthenia—Etoposide—prostate cancer	0.000176	0.000313	CcSEcCtD
Icosapent ethyl—Dyspnoea—Capecitabine—prostate cancer	0.000176	0.000313	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Prednisone—prostate cancer	0.000175	0.000313	CcSEcCtD
Icosapent ethyl—Oedema—Prednisone—prostate cancer	0.000175	0.000313	CcSEcCtD
Icosapent ethyl—Infection—Prednisone—prostate cancer	0.000174	0.000311	CcSEcCtD
Icosapent ethyl—Constipation—Docetaxel—prostate cancer	0.000174	0.00031	CcSEcCtD
Icosapent ethyl—Pain—Docetaxel—prostate cancer	0.000174	0.00031	CcSEcCtD
Icosapent ethyl—Dyspepsia—Capecitabine—prostate cancer	0.000173	0.000309	CcSEcCtD
Icosapent ethyl—Chills—Epirubicin—prostate cancer	0.000173	0.000309	CcSEcCtD
Icosapent ethyl—Pruritus—Etoposide—prostate cancer	0.000173	0.000309	CcSEcCtD
Icosapent ethyl—Shock—Prednisone—prostate cancer	0.000173	0.000308	CcSEcCtD
Icosapent ethyl—Arrhythmia—Epirubicin—prostate cancer	0.000172	0.000308	CcSEcCtD
Icosapent ethyl—Tachycardia—Prednisone—prostate cancer	0.000171	0.000305	CcSEcCtD
Icosapent ethyl—Decreased appetite—Capecitabine—prostate cancer	0.000171	0.000305	CcSEcCtD
Icosapent ethyl—Alopecia—Epirubicin—prostate cancer	0.000171	0.000304	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Capecitabine—prostate cancer	0.00017	0.000303	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Prednisone—prostate cancer	0.00017	0.000303	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—PIK3CD—prostate cancer	0.000169	0.000591	CbGpPWpGaD
Icosapent ethyl—Constipation—Capecitabine—prostate cancer	0.000168	0.0003	CcSEcCtD
Icosapent ethyl—Pain—Capecitabine—prostate cancer	0.000168	0.0003	CcSEcCtD
Icosapent ethyl—Malnutrition—Epirubicin—prostate cancer	0.000168	0.0003	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Docetaxel—prostate cancer	0.000168	0.000299	CcSEcCtD
Icosapent ethyl—Anorexia—Prednisone—prostate cancer	0.000167	0.000298	CcSEcCtD
Icosapent ethyl—Dysgeusia—Epirubicin—prostate cancer	0.000165	0.000294	CcSEcCtD
Icosapent ethyl—Back pain—Epirubicin—prostate cancer	0.000163	0.00029	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Capecitabine—prostate cancer	0.000162	0.000289	CcSEcCtD
Icosapent ethyl—Dizziness—Etoposide—prostate cancer	0.000162	0.000289	CcSEcCtD
Icosapent ethyl—Body temperature increased—Docetaxel—prostate cancer	0.000161	0.000287	CcSEcCtD
Icosapent ethyl—Chills—Doxorubicin—prostate cancer	0.00016	0.000286	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—NOS3—prostate cancer	0.00016	0.000558	CbGpPWpGaD
Icosapent ethyl—Musculoskeletal discomfort—Prednisone—prostate cancer	0.00016	0.000285	CcSEcCtD
Icosapent ethyl—Arrhythmia—Doxorubicin—prostate cancer	0.00016	0.000285	CcSEcCtD
Icosapent ethyl—Insomnia—Prednisone—prostate cancer	0.000159	0.000283	CcSEcCtD
Icosapent ethyl—Alopecia—Doxorubicin—prostate cancer	0.000158	0.000282	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Epirubicin—prostate cancer	0.000156	0.000278	CcSEcCtD
Icosapent ethyl—Body temperature increased—Capecitabine—prostate cancer	0.000156	0.000278	CcSEcCtD
Icosapent ethyl—Vomiting—Etoposide—prostate cancer	0.000156	0.000278	CcSEcCtD
Icosapent ethyl—Malnutrition—Doxorubicin—prostate cancer	0.000156	0.000277	CcSEcCtD
Icosapent ethyl—Dyspepsia—Prednisone—prostate cancer	0.000154	0.000275	CcSEcCtD
Icosapent ethyl—Rash—Etoposide—prostate cancer	0.000154	0.000275	CcSEcCtD
Icosapent ethyl—Dermatitis—Etoposide—prostate cancer	0.000154	0.000275	CcSEcCtD
Icosapent ethyl—Decreased appetite—Prednisone—prostate cancer	0.000152	0.000272	CcSEcCtD
Icosapent ethyl—Dysgeusia—Doxorubicin—prostate cancer	0.000152	0.000272	CcSEcCtD
Icosapent ethyl—Malaise—Epirubicin—prostate cancer	0.000152	0.00027	CcSEcCtD
Icosapent ethyl—Vertigo—Epirubicin—prostate cancer	0.000151	0.000269	CcSEcCtD
Icosapent ethyl—Syncope—Epirubicin—prostate cancer	0.000151	0.000269	CcSEcCtD
Icosapent ethyl—Back pain—Doxorubicin—prostate cancer	0.00015	0.000268	CcSEcCtD
Icosapent ethyl—Constipation—Prednisone—prostate cancer	0.00015	0.000268	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Epirubicin—prostate cancer	0.000148	0.000264	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—PIK3CB—prostate cancer	0.000148	0.000515	CbGpPWpGaD
Icosapent ethyl—Cough—Epirubicin—prostate cancer	0.000147	0.000262	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—PTGS2—prostate cancer	0.000146	0.000511	CbGpPWpGaD
Icosapent ethyl—Asthenia—Docetaxel—prostate cancer	0.000146	0.00026	CcSEcCtD
Icosapent ethyl—Hypertension—Epirubicin—prostate cancer	0.000145	0.000259	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Prednisone—prostate cancer	0.000145	0.000258	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Doxorubicin—prostate cancer	0.000144	0.000257	CcSEcCtD
Icosapent ethyl—Pruritus—Docetaxel—prostate cancer	0.000144	0.000257	CcSEcCtD
Icosapent ethyl—Arthralgia—Epirubicin—prostate cancer	0.000143	0.000255	CcSEcCtD
Icosapent ethyl—Myalgia—Epirubicin—prostate cancer	0.000143	0.000255	CcSEcCtD
Icosapent ethyl—Chest pain—Epirubicin—prostate cancer	0.000143	0.000255	CcSEcCtD
Icosapent ethyl—Discomfort—Epirubicin—prostate cancer	0.000141	0.000252	CcSEcCtD
Icosapent ethyl—Asthenia—Capecitabine—prostate cancer	0.000141	0.000252	CcSEcCtD
Icosapent ethyl—Malaise—Doxorubicin—prostate cancer	0.00014	0.00025	CcSEcCtD
Icosapent ethyl—Dry mouth—Epirubicin—prostate cancer	0.00014	0.00025	CcSEcCtD
Icosapent ethyl—Vertigo—Doxorubicin—prostate cancer	0.00014	0.000249	CcSEcCtD
Icosapent ethyl—Syncope—Doxorubicin—prostate cancer	0.000139	0.000249	CcSEcCtD
Icosapent ethyl—Pruritus—Capecitabine—prostate cancer	0.000139	0.000249	CcSEcCtD
Icosapent ethyl—Body temperature increased—Prednisone—prostate cancer	0.000139	0.000247	CcSEcCtD
Icosapent ethyl—Oedema—Epirubicin—prostate cancer	0.000137	0.000245	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Epirubicin—prostate cancer	0.000137	0.000245	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Doxorubicin—prostate cancer	0.000137	0.000244	CcSEcCtD
Icosapent ethyl—Infection—Epirubicin—prostate cancer	0.000136	0.000243	CcSEcCtD
Icosapent ethyl—Cough—Doxorubicin—prostate cancer	0.000136	0.000242	CcSEcCtD
Icosapent ethyl—Shock—Epirubicin—prostate cancer	0.000135	0.000241	CcSEcCtD
Icosapent ethyl—Dizziness—Docetaxel—prostate cancer	0.000134	0.00024	CcSEcCtD
Icosapent ethyl—Hypertension—Doxorubicin—prostate cancer	0.000134	0.00024	CcSEcCtD
Icosapent ethyl—Tachycardia—Epirubicin—prostate cancer	0.000134	0.000239	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Epirubicin—prostate cancer	0.000133	0.000237	CcSEcCtD
Icosapent ethyl—Myalgia—Doxorubicin—prostate cancer	0.000132	0.000236	CcSEcCtD
Icosapent ethyl—Chest pain—Doxorubicin—prostate cancer	0.000132	0.000236	CcSEcCtD
Icosapent ethyl—Arthralgia—Doxorubicin—prostate cancer	0.000132	0.000236	CcSEcCtD
Icosapent ethyl—Discomfort—Doxorubicin—prostate cancer	0.000131	0.000233	CcSEcCtD
Icosapent ethyl—Anorexia—Epirubicin—prostate cancer	0.000131	0.000233	CcSEcCtD
Icosapent ethyl—Dizziness—Capecitabine—prostate cancer	0.00013	0.000232	CcSEcCtD
Icosapent ethyl—Dry mouth—Doxorubicin—prostate cancer	0.000129	0.000231	CcSEcCtD
Icosapent ethyl—Vomiting—Docetaxel—prostate cancer	0.000129	0.000231	CcSEcCtD
Icosapent ethyl—Rash—Docetaxel—prostate cancer	0.000128	0.000229	CcSEcCtD
Icosapent ethyl—Dermatitis—Docetaxel—prostate cancer	0.000128	0.000229	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—PTEN—prostate cancer	0.000128	0.000445	CbGpPWpGaD
Icosapent ethyl—Anaphylactic shock—Doxorubicin—prostate cancer	0.000127	0.000226	CcSEcCtD
Icosapent ethyl—Oedema—Doxorubicin—prostate cancer	0.000127	0.000226	CcSEcCtD
Icosapent ethyl—Infection—Doxorubicin—prostate cancer	0.000126	0.000225	CcSEcCtD
Icosapent ethyl—Asthenia—Prednisone—prostate cancer	0.000126	0.000225	CcSEcCtD
Icosapent ethyl—Vomiting—Capecitabine—prostate cancer	0.000125	0.000223	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.000125	0.000223	CcSEcCtD
Icosapent ethyl—Shock—Doxorubicin—prostate cancer	0.000125	0.000223	CcSEcCtD
Icosapent ethyl—Rash—Capecitabine—prostate cancer	0.000124	0.000222	CcSEcCtD
Icosapent ethyl—Pruritus—Prednisone—prostate cancer	0.000124	0.000221	CcSEcCtD
Icosapent ethyl—Insomnia—Epirubicin—prostate cancer	0.000124	0.000221	CcSEcCtD
Icosapent ethyl—Dermatitis—Capecitabine—prostate cancer	0.000124	0.000221	CcSEcCtD
Icosapent ethyl—Tachycardia—Doxorubicin—prostate cancer	0.000124	0.000221	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Doxorubicin—prostate cancer	0.000123	0.000219	CcSEcCtD
Icosapent ethyl—Dyspnoea—Epirubicin—prostate cancer	0.000122	0.000218	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—EP300—prostate cancer	0.000122	0.000425	CbGpPWpGaD
Icosapent ethyl—Anorexia—Doxorubicin—prostate cancer	0.000121	0.000216	CcSEcCtD
Icosapent ethyl—Dyspepsia—Epirubicin—prostate cancer	0.000121	0.000215	CcSEcCtD
Icosapent ethyl—Decreased appetite—Epirubicin—prostate cancer	0.000119	0.000213	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000118	0.000211	CcSEcCtD
Icosapent ethyl—Pain—Epirubicin—prostate cancer	0.000117	0.000209	CcSEcCtD
Icosapent ethyl—Constipation—Epirubicin—prostate cancer	0.000117	0.000209	CcSEcCtD
Icosapent ethyl—Dizziness—Prednisone—prostate cancer	0.000116	0.000207	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Doxorubicin—prostate cancer	0.000116	0.000206	CcSEcCtD
Icosapent ethyl—Insomnia—Doxorubicin—prostate cancer	0.000115	0.000205	CcSEcCtD
Icosapent ethyl—Dyspnoea—Doxorubicin—prostate cancer	0.000113	0.000202	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Epirubicin—prostate cancer	0.000113	0.000202	CcSEcCtD
Icosapent ethyl—Dyspepsia—Doxorubicin—prostate cancer	0.000112	0.000199	CcSEcCtD
Icosapent ethyl—Vomiting—Prednisone—prostate cancer	0.000112	0.000199	CcSEcCtD
Icosapent ethyl—Rash—Prednisone—prostate cancer	0.000111	0.000197	CcSEcCtD
Icosapent ethyl—Dermatitis—Prednisone—prostate cancer	0.00011	0.000197	CcSEcCtD
Icosapent ethyl—Decreased appetite—Doxorubicin—prostate cancer	0.00011	0.000197	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.00011	0.000196	CcSEcCtD
Icosapent ethyl—Constipation—Doxorubicin—prostate cancer	0.000109	0.000194	CcSEcCtD
Icosapent ethyl—Pain—Doxorubicin—prostate cancer	0.000109	0.000194	CcSEcCtD
Icosapent ethyl—Body temperature increased—Epirubicin—prostate cancer	0.000108	0.000193	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Doxorubicin—prostate cancer	0.000105	0.000187	CcSEcCtD
Icosapent ethyl—Body temperature increased—Doxorubicin—prostate cancer	0.0001	0.000179	CcSEcCtD
Icosapent ethyl—Asthenia—Epirubicin—prostate cancer	9.84e-05	0.000176	CcSEcCtD
Icosapent ethyl—Pruritus—Epirubicin—prostate cancer	9.7e-05	0.000173	CcSEcCtD
Icosapent ethyl—Asthenia—Doxorubicin—prostate cancer	9.11e-05	0.000162	CcSEcCtD
Icosapent ethyl—Dizziness—Epirubicin—prostate cancer	9.07e-05	0.000162	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—PIK3CA—prostate cancer	9e-05	0.000314	CbGpPWpGaD
Icosapent ethyl—Pruritus—Doxorubicin—prostate cancer	8.98e-05	0.00016	CcSEcCtD
Icosapent ethyl—Vomiting—Epirubicin—prostate cancer	8.72e-05	0.000156	CcSEcCtD
Icosapent ethyl—Rash—Epirubicin—prostate cancer	8.65e-05	0.000154	CcSEcCtD
Icosapent ethyl—Dermatitis—Epirubicin—prostate cancer	8.64e-05	0.000154	CcSEcCtD
Icosapent ethyl—Dizziness—Doxorubicin—prostate cancer	8.39e-05	0.00015	CcSEcCtD
Icosapent ethyl—Vomiting—Doxorubicin—prostate cancer	8.07e-05	0.000144	CcSEcCtD
Icosapent ethyl—Rash—Doxorubicin—prostate cancer	8e-05	0.000143	CcSEcCtD
Icosapent ethyl—Dermatitis—Doxorubicin—prostate cancer	7.99e-05	0.000143	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—AKT1—prostate cancer	7.35e-05	0.000257	CbGpPWpGaD
